Young-Rok Do

479 total citations
39 papers, 335 citations indexed

About

Young-Rok Do is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Young-Rok Do has authored 39 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Epidemiology. Recurrent topics in Young-Rok Do's work include Lymphoma Diagnosis and Treatment (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Acute Ischemic Stroke Management (5 papers). Young-Rok Do is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Acute Ischemic Stroke Management (5 papers). Young-Rok Do collaborates with scholars based in South Korea, United States and Czechia. Young-Rok Do's co-authors include Sophia Zackrisson, Dev P. Chakraborty, Tony Svahn, Debra M. Ikeda, S. Mattsson, Ingvar Andersson, Dong Kuck Lee, Jin‐Man Jung, Hyeon‐Seok Eom and Hye Jin Kang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Young-Rok Do

32 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Young-Rok Do South Korea 9 151 85 79 72 69 39 335
Andrew Thornton United Kingdom 10 96 0.6× 226 2.7× 39 0.5× 54 0.8× 37 0.5× 20 413
Julie Cox United Kingdom 12 93 0.6× 78 0.9× 12 0.2× 53 0.7× 39 0.6× 32 376
I. Neetens Belgium 11 147 1.0× 48 0.6× 12 0.2× 40 0.6× 39 0.6× 25 354
Antoine Iannessi France 12 104 0.7× 150 1.8× 21 0.3× 77 1.1× 14 0.2× 46 371
Kate Mahady United Kingdom 6 126 0.8× 55 0.6× 25 0.3× 57 0.8× 95 1.4× 9 333
Heng Cao China 11 103 0.7× 22 0.3× 10 0.1× 77 1.1× 94 1.4× 37 358
Julian M.M. Rogasch Germany 15 217 1.4× 360 4.2× 27 0.3× 70 1.0× 62 0.9× 63 570
Ji Youn Kim South Korea 11 43 0.3× 183 2.2× 16 0.2× 84 1.2× 39 0.6× 31 449
Minghao Li China 12 102 0.7× 92 1.1× 34 0.4× 80 1.1× 32 0.5× 40 353
Patricia Martin United Kingdom 7 41 0.3× 202 2.4× 56 0.7× 17 0.2× 24 0.3× 10 336

Countries citing papers authored by Young-Rok Do

Since Specialization
Citations

This map shows the geographic impact of Young-Rok Do's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young-Rok Do with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young-Rok Do more than expected).

Fields of papers citing papers by Young-Rok Do

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young-Rok Do. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young-Rok Do. The network helps show where Young-Rok Do may publish in the future.

Co-authorship network of co-authors of Young-Rok Do

This figure shows the co-authorship network connecting the top 25 collaborators of Young-Rok Do. A scholar is included among the top collaborators of Young-Rok Do based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young-Rok Do. Young-Rok Do is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bae, Hyoeun, Keun Tae Kim, Mi Hwa Heo, Young-Rok Do, & Yong Won Cho. (2021). The prevalence and clinical characteristics of restless legs syndrome in patients with iron deficiency anemia in Korea. Journal of Clinical Sleep Medicine. 17(7). 1447–1452. 11 indexed citations
3.
Do, Young-Rok, et al.. (2018). Clinical approach to patients with dizziness. Journal of Korean Medical Association. 61(1). 44–44. 1 indexed citations
4.
Kim, Seung Ju, Jin Sung Kim, Dok Hyun Yoon, et al.. (2016). A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas. Annals of Oncology. 27(4). 712–718. 39 indexed citations
5.
Shin, Ho‐Jin, Dok Hyun Yoon, Ho Sup Lee, et al.. (2015). Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B-cell lymphoma patients. Experimental Hematology. 44(1). 3–13. 6 indexed citations
6.
Jung, Jin‐Man, Hyun Jung Kim, Hyeong Sik Ahn, et al.. (2015). Chronic kidney disease and intravenous thrombolysis in acute stroke: A systematic review and meta-analysis. Journal of the Neurological Sciences. 358(1-2). 345–350. 34 indexed citations
7.
Jung, Jin‐Man, Jong‐Young Lee, Hye‐Jin Kim, et al.. (2013). Patent Foramen Ovale and Infarct Volume in Cryptogenic Stroke. Journal of Stroke and Cerebrovascular Diseases. 22(8). 1399–1404. 17 indexed citations
8.
Shin, Ho‐Jin, Joon Ho Moon, Je‐Jung Lee, et al.. (2012). Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment. Annals of Hematology. 91(6). 889–896. 6 indexed citations
9.
Svahn, Tony, Dev P. Chakraborty, Debra M. Ikeda, et al.. (2012). Breast tomosynthesis and digital mammography: a comparison of diagnostic accuracy. British Journal of Radiology. 85(1019). e1074–e1082. 116 indexed citations
10.
Lopes, Gilberto, Joel E. Segel, Daniel Shao-Weng Tan, et al.. (2011). OP3 Cost-effectiveness of epidermal growth-factor receptor mutation testing and first-line treatment with gefitinib for advanced non-small-cell lung cancer. European Journal of Cancer Supplements. 9(1). 2–2. 2 indexed citations
11.
12.
Koh, Young‐Il, Jae Hoon Lee, Hwi‐Joong Yoon, et al.. (2009). Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide. Annals of Hematology. 89(2). 201–206. 26 indexed citations
13.
Lee, Sang‐Min, et al.. (2008). A case of small cell carcinoma of the uterine cervix. The Korean Journal of Internal Medicine. 74(2). 208–212.
14.
Kim, Jinyoung, et al.. (2007). Primary small cell carcinoma of the ovary and the long-term survival after systemic chemotherapy. The Korean Journal of Internal Medicine. 72(5). 563–567. 3 indexed citations
15.
Kim, Yong Jin, et al.. (2007). The efficacy of concurrent chemoradiotherapy for patients with inoperable esophageal cancer. The Korean Journal of Internal Medicine. 72(1). 37–43. 1 indexed citations
16.
Kim, Seok Jin, Hyo Jin Lee, Hawk Kim, et al.. (2007). Varicella Zoster Virus Reactivation with the Use of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients.. Blood. 110(11). 4843–4843.
17.
Lee, Sang‐Won, et al.. (2005). A case of primary gastric choriocarcinoma associated with adenocarcinoma. The Korean Journal of Internal Medicine. 68(1). 83–88.
18.
Do, Young-Rok, et al.. (2005). A Case of Bickerstaff's Brainstem Encephalitis with Guillain-Barre Syndrome Presenting Optic Neuropathy and Seizure.. Journal of the Korean Neurological Association. 23(3). 389–391.
19.
Yang, Deok‐Hwan, Je‐Jung Lee, Yeo‐Kyeoung Kim, et al.. (2004). The Clinical Efficacy of R-CHOP Chemotherapy in Patients with Previously Untreated Diffuse Large B-cell Lymphoma. Blood Research. 39(2). 59–65. 2 indexed citations
20.
Laasch, Hans‐Ulrich, Derrick Martin, Young-Rok Do, Martin Köcher, & P.J. Valette. (2003). Interventional Radiology for the Management of Inoperable Carcinoma of the Oesophagus. Endoscopy. 35(12). 1049–1058. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Thornton Breakdown of academic impact, for papers by Julie Cox Breakdown of academic impact, for papers by I. Neetens Breakdown of academic impact, for papers by Antoine Iannessi Breakdown of academic impact, for papers by Kate Mahady Breakdown of academic impact, for papers by Heng Cao Breakdown of academic impact, for papers by Julian M.M. Rogasch Breakdown of academic impact, for papers by Ji Youn Kim Breakdown of academic impact, for papers by Minghao Li Breakdown of academic impact, for papers by Patricia Martin
Rankless by CCL
2026